FDA issues 'stop work' to makers of famous 'Amruttulya' tea

Image
Press Trust of India Pune
Last Updated : Sep 25 2019 | 6:00 PM IST

Food and Drug Administration (FDA) department of the Maharashtra government has issued a 'stop work' notice to famous tea chain, Yewale Food Products, makers of "Amruttulya" tea, over alleged violations of Food Safety and Standards Act, officials said on Wednesday.

Officials have seized samples of sugar, tea, and tea 'masala' after a media report claimed that some addictive was allegedly used in the brew.

Yewale Food Products prepare packages of sugar, tea, and special tea masalas at their centralised manufacturing unit at Katraj in Pune and send them to their tea franchises, famously known as "Yewle Amtruttulya", in various cities.

According to Food and Drug Administration (FDA) department officials, an inspection was conducted at the Katraj unit.

"We found the products were without mandatory labels mentioning content of the ingrediants as well as the manufacturing and expiry dates. The labels are mandatory under the Food Safety and Standards Act," an official said.

The FDA also found the chain had not deputed a qualified person to supervise the manufacturing and packaging process.

He said the advertisement that tea-drinkers will not have any acidity problem after drinking "Amruttulya" tea prima facie seems misleading.

"Their claim of using mineral water for preparing tea is also misleading," he said.

A stop-work notice has been issued until the firm complies with the FDA norms, he added.

"They have been directed to not manufacture the ready-to-use mixtures and package them until then," the official said.

He said some samples of sugar, tea, and the tea 'masala' have been seized, which will be analysed at the FDA laboratory.

"The samples were collected after a report in a weekly claiming that some addictive is being mixed in the tea," the official informed.

When contacted, founder of the tea chain Nannath Yewale said they have complied with all the legal norms and sent a report to the FDA.

He refuted allegations of usage of 'addictive', saying they are baseless and aimed at defaming the reputation of the tea chain.

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Sep 25 2019 | 6:00 PM IST

Next Story